Thomas Catinazzo is CFO at Relay Therapeutics, Inc. (RLAY). They have made 34 open-market trades across 1 company since 2021, most recently 2026-10-06.
CIK 0001818261
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 34 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RLAY | 105,134 | $1.7M |
Shares reported on the most recent Form 4, priced at the 2026-10-08 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RLAY | SELL · 10b5-1 | 2026-10-06 | 2026-10-08 | $18.59 | $329K | — | — | — |
| RLAY | SELL · 10b5-1 | 2026-09-08 | 2026-09-09 | $18.94 | $336K | -1.4% | -3.1% | — |
| RLAY | SELL · 10b5-1 | 2026-08-14 | 2026-08-18 | $19.74 | $350K | -11.2% | -9.3% | — |
| RLAY | SELL | 2026-07-28 | 2026-07-30 | $18.61 | $27K | +2.8% | -5.6% | — |
| RLAY | SELL · 10b5-1 | 2026-07-06 | 2026-07-08 | $18.69 | $331K | -2.8% | +0.4% | -4.9% |
| RLAY | SELL · 10b5-1 | 2026-06-22 | 2026-06-24 | $16.97 | $3.2M | +7.9% | +0.8% | +6.0% |
| RLAY | SELL · 10b5-1 | 2026-05-14 | 2026-05-14 | $12.86 | $228K | +15.1% | +19.6% | +60.3% |
| RLAY | SELL | 2026-04-28 | 2026-04-30 | $14.79 | $14K | +0.6% | +11.1% | +42.9% |
| RLAY | SELL · 10b5-1 | 2026-04-07 | 2026-04-09 | $13.19 | $257K | +12.0% | -14.4% | +30.8% |
| RLAY | SELL | 2026-03-09 | 2026-03-11 | $10.06 | $178K | -8.5% | +39.2% | +31.4% |
| RLAY | SELL | 2026-01-27 | 2026-01-29 | $7.71 | $120K | +16.8% | +27.1% | +62.9% |
| RLAY | SELL | 2025-10-28 | 2025-10-30 | $7.29 | $316K | -14.2% | +1.0% | +4.4% |
| RLAY | SELL | 2025-07-28 | 2025-07-30 | $3.68 | $142K | -8.5% | +1.1% | +111.8% |
| RLAY | SELL · 10b5-1 | 2025-04-28 | 2025-04-30 | $3.07 | $59K | -6.3% | -9.6% | +9.0% |
| RLAY | SELL · 10b5-1 | 2025-03-27 | 2025-03-31 | $2.84 | $14K | -14.0% | +29.1% | +34.1% |
| RLAY | SELL · 10b5-1 | 2025-01-28 | 2025-01-30 | $4.55 | $517K | -18.3% | -30.1% | -27.3% |
| RLAY | SELL · 10b5-1 | 2024-12-27 | 2024-12-31 | $4.42 | $21K | +4.7% | +9.4% | -36.9% |
| RLAY | SELL · 10b5-1 | 2024-10-28 | 2024-10-30 | $6.03 | $55K | +7.9% | -17.7% | -19.1% |
| RLAY | SELL · 10b5-1 | 2024-09-27 | 2024-10-01 | $7.46 | $48K | +4.3% | -13.6% | -35.9% |
| RLAY | SELL · 10b5-1 | 2024-07-29 | 2024-07-31 | $8.54 | $170K | -20.1% | -16.7% | -27.6% |
| RLAY | SELL · 10b5-1 | 2024-06-27 | 2024-07-01 | $6.24 | $115K | +30.0% | +29.7% | +11.7% |
| RLAY | SELL | 2024-04-29 | 2024-04-29 | $6.38 | $11K | -2.2% | -4.0% | +27.4% |
| RLAY | SELL | 2024-03-27 | 2024-03-29 | $7.70 | $3K | -16.9% | -20.6% | -24.1% |
| RLAY | SELL | 2024-01-29 | 2024-01-31 | $9.64 | $19K | +2.3% | +8.9% | -29.6% |
| RLAY | SELL | 2023-12-27 | 2023-12-29 | $11.51 | $3K | +5.7% | -7.7% | -22.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.